Latest for Hereditary Spastic Paraplegia Type 4
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- Trial statusNo longer enrolling. Flexibility, Resistance, Aerobic, Movement Execution Training in Adults With… (IRCCS Eugenio Medea)ClinicalTrials.gov
More about Hereditary Spastic Paraplegia Type 4
This length-dependent axonopathy particularly affects the longest neurons because they have the greatest energy and transport demands. Patients experience slowly progressive lower limb weakness and spasticity (increased muscle tone and reflexes), with highly variable age of onset ranging from childhood to late adulthood. Early-onset forms (childhood-onset) tend to progress more rapidly and lead to significant disability sooner, while late-onset forms may be relatively benign with minimal functional impact during normal lifespan.
Keep reading about Hereditary Spastic Paraplegia Type 4
As disease progresses, patients develop increasing difficulty ambulating with progressive spasticity and weakness, with some becoming wheelchair-dependent by middle age while others maintain independent ambulation throughout life. Cognitive decline occurs in some family lineages. MRI may show progressive spinal cord atrophy reflecting neuronal loss. Life expectancy is typically normal or only slightly reduced.
What are the symptoms of Hereditary Spastic Paraplegia Type 4?
These are common symptoms of Hereditary Spastic Paraplegia Type 4, and how strong they are varies from person to person.
- Progressive lower limb weakness and stiffness
- Spasticity affecting legs and feet
- Hyperreflexia and Babinski sign
- Difficulty walking and balance problems
- Urinary urgency and incontinence
- Cognitive decline in some cases
Who gets Hereditary Spastic Paraplegia Type 4?
Hereditary spastic paraplegia type 4 has highly variable age of onset from childhood to late adulthood, even within families. SPG4 mutations account for approximately 40% of hereditary spastic paraplegia cases overall.
The condition affects males and females equally. Since it follows autosomal dominant inheritance with incomplete penetrance, approximately 50% of offspring of affected parents inherit mutations, though some carriers may not manifest clinical disease. Penetrance appears to increase with age.
Next steps: find trials you might fitsee what is being testedget help payingget alerts
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Hereditary Spastic Paraplegia Type 4
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Hereditary Spastic Paraplegia Type 4 resources
Reputable organizations and medical references for learning more about Hereditary Spastic Paraplegia Type 4, including disease registries, foundation resources, and clinical guidelines.